These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 7091830)

  • 21. Risk factors related to the prevalence of infectious bovine keratoconjunctivitis.
    Webber JJ; Selby LA
    J Am Vet Med Assoc; 1981 Oct; 179(8):823-6. PubMed ID: 6281222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of aflatoxin ingestion on the development of Moraxella bovis infectious bovine keratoconjunctivitis.
    Pugh GW; Richard JL; Kopecky KE; McDonald TJ
    Cornell Vet; 1984 Apr; 74(2):96-110. PubMed ID: 6467950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
    Angelos JA; Gohary KG; Ball LM; Hess JF
    Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectious bovine keratoconjunctivitis: influence of age on development of disease in vaccinated and nonvaccinated calves after exposure to Moraxella bovis.
    Pugh GW; McDonald TJ; Booth GD
    Am J Vet Res; 1979 Jun; 40(6):762-6. PubMed ID: 475126
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimentally induced infections bovine keratoconjunctivitis: effectiveness of a pilus vaccine against exposure to homologous strains of Moraxella bovis.
    Pugh GW; Hughes DE; Booth GD
    Am J Vet Res; 1977 Oct; 38(10):1519-22. PubMed ID: 931134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of Moraxella bovis hemolysin.
    Ostle AG; Rosenbusch RF
    Am J Vet Res; 1985 May; 46(5):1011-4. PubMed ID: 2408520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimentally induced infectious bovine keratoconjunctivitis: resistance of vaccinated cattle to homologous and heterologous strains of Moraxella bovis.
    Pugh GW; Hughes DE; Schulz VD; Graham CK
    Am J Vet Res; 1976 Jan; 37(1):57-60. PubMed ID: 1247198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wavelength of ultraviolet radiation that enhances onset of clinical infectious bovine keratoconjunctivitis.
    Kopecky KE; Pugh GW; Hughes DE
    Am J Vet Res; 1980 Sep; 41(9):1412-5. PubMed ID: 7447134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimentally induced infectious bovine keratoconjunctivitis: potentiation of a Moraxella bovis pilus vaccine's immunogenicity by vaccination with Mycobacterium paratuberculosis bacterin.
    Pugh GW; McDonald TJ; Larsen AB
    Am J Vet Res; 1978 Oct; 39(10):1656-61. PubMed ID: 717879
    [No Abstract]   [Full Text] [Related]  

  • 30. Bovine infectious keratoconjunctivitis: carrier state of Moraxella bovis and the development of preventive measures against disease.
    Pugh GW; Hughes DE
    J Am Vet Med Assoc; 1975 Aug; 167(4):310-3. PubMed ID: 1097382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined parenteral and oral administration of oxytetracycline for control of infectious bovine keratoconjunctivitis.
    Eastman TG; George LW; Hird DW; Thurmond MC
    J Am Vet Med Assoc; 1998 Feb; 212(4):560-3. PubMed ID: 9491167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of infectious bovine keratoconjunctivitis by modified-live infectious bovine rhinotracheitis virus vaccine.
    George LW; Ardans A; Mihalyi J; Guerra MR
    Am J Vet Res; 1988 Nov; 49(11):1800-6. PubMed ID: 2854704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serologic and protective characterization of Moraxella bovis pili.
    Lehr C; Jayappa HG; Goodnow RA
    Cornell Vet; 1985 Oct; 75(4):484-92. PubMed ID: 2865080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Hess JF; George LW
    Vaccine; 2004 Dec; 23(4):537-45. PubMed ID: 15530703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of a cytolysin-enriched vaccine for protection of cattle against infectious bovine keratoconjunctivitis.
    George LW; Borrowman AJ; Angelos JA
    Am J Vet Res; 2005 Jan; 66(1):136-42. PubMed ID: 15691049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized and blinded field trial to assess the efficacy of an autogenous vaccine to prevent naturally occurring infectious bovine keratoconjunctivis (IBK) in beef calves.
    Funk L; O'Connor AM; Maroney M; Engelken T; Cooper VL; Kinyon J; Plummer P
    Vaccine; 2009 Jul; 27(34):4585-90. PubMed ID: 19531391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acute ocular Moraxella bovis infections in calves with a parenterally administered long-acting oxytetracycline formulation.
    Smith JA; George LW
    Am J Vet Res; 1985 Apr; 46(4):804-7. PubMed ID: 4014830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of Moraxella bovis antibodies in the SIgA, IgG, and IgM classes of immunoglobulin in bovine lacrimal secretions by an indirect fluorescent antibody test.
    Killinger AH; Weisiger RM; Helper LC; Mansfield ME
    Am J Vet Res; 1978 Jun; 39(6):931-4. PubMed ID: 352205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimentally induced infectious bovine keratoconjunctivitis: vaccination with nonviable Moraxella bovis culture.
    Hughes DE; Pugh GW
    Am J Vet Res; 1972 Dec; 33(12):2475-9. PubMed ID: 4641206
    [No Abstract]   [Full Text] [Related]  

  • 40. Serologic cross-reactivity of Australian Moraxella bovis to vaccinal bacterin strains as determined by competitive ELISA.
    McConnel CS; Shum L; Gleeson BL; House JK
    Aust Vet J; 2008 Apr; 86(4):124-9. PubMed ID: 18363984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.